A model system that predicts effective half-life for radiolabeled antibody therapy
- 1 August 1985
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 11 (8) , 1489-1494
- https://doi.org/10.1016/0360-3016(85)90337-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Variables affecting the tumor localization of131 I-antiferritin in experimental hepatomaAmerican Journal of Clinical Oncology, 1984
- Selective tumor localization in experimental hepatoma by radiolabeled antiferritin antibodyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- PHASE-I CLINICAL TRIAL OF MONOCLONAL ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMOURSThe Lancet, 1982
- Tumor Imaging with Radioactive Metal Chelates Conjugated to Monoclonal AntibodiesScience, 1982
- RESPONSE OF CUTANEOUS T CELL LYMPHOMA TO THERAPY WITH HYBRIDOMA MONOCLONAL ANTIBODYThe Lancet, 1981
- Tumor Localization of Radio-Labeled Antibodies against Carcinoembryonic Antigen in Patients with CarcinomaNew England Journal of Medicine, 1980
- Phase I–II study of radiolabeled antibody integrated in the treatment of primary hepatic malignanciesInternational Journal of Radiation Oncology*Biology*Physics, 1980
- SEROTHERAPY OF A PATIENT WITH A MONOCLONAL-ANTIBODY DIRECTED AGAINST A HUMAN LYMPHOMA-ASSOCIATED ANTIGEN1980
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978
- THE USE OF PAIRED LABELING IN THE DETERMINATION OF TUMOR-LOCALIZING ANTIBODIES1957